Targeting Joint Engagement in Infants at Risk for ASD: Integrating Treatment with Biomarkers

Keywords: ASD, >12 months, <21 months, Biomarkers of Treatment Outcomes in Neurodevelopmental Disorders

What is being studied?

The purpose of this study is to implement a parent-mediated clinical intervention to address social and communicative delays in infants. Because brain development occurs rapidly in infants and toddlers, EEG is being used to closely track biomarkers of functional changes in the brain from intervention, as well as biomarkers predicting response to treatment. We are focused on neural correlates of social attention, face processing, and learning from joint engagement.

Who can participate?

If you have a child between the 12 and 21 months of age, and have concerns over their social communication development, you and your child may be eligible to participate in this study. Your child must not have any previously diagnosed sensory or physical disorders. A participating parent must be available for two sessions per week at UCLA.

Whom should I contact to get involved?

If you are interested in participating in this study, please contact the Kasari Lab at (310) 206-1268

Leave a Reply

Your email address will not be published.